Coats Plus Syndrome in a Premature Infant, With a Focus on Management

Avery E Sears1, Caroline C Awh2, Shafeeque Kunhiabdullah3

  • 1Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Insights

Genetic testing identified pathogenic CTC1 variants, diagnosing Coats plus syndrome in a premature infant. This rare genetic disorder caused significant retinal issues, requiring targeted treatment.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatrics

Background:

  • Coats plus syndrome is a rare genetic disorder.
  • It is characterized by retinovascular ischemia, capillary remodeling, aneurysmal dilation, and exudative retinal detachment.
  • Pathogenic variants in the CTC1 gene are associated with Coats plus syndrome.

Observation:

  • A premature infant born at 30 weeks gestational age presented with symptoms suggestive of Coats plus syndrome.
  • Ophthalmic examination revealed exudative retinal detachment in one eye and avascularity with telangiectasias and aneurysmal dilations in the other.
  • Genetic evaluation confirmed biallelic heterozygous pathogenic CTC1 variants.

Findings:

  • The infant was diagnosed with Coats plus syndrome based on genetic findings.
  • Despite initial treatment with photocoagulation, retinal ischemia progressed.
  • Sequential examinations under anesthesia with fluorescein angiography documented progressive ischemia.

Implications:

  • Early genetic diagnosis of Coats plus syndrome is crucial for appropriate management.
  • A combination of systemic/local corticosteroids and laser ablation effectively reduced vascular exudation.
  • This multimodal approach helped avoid more invasive intraocular interventions.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
203
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
226
Coat Assembly and GTPases01:33

Coat Assembly and GTPases

Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
3.6K
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
663
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
17
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
21